With just over one month to go until Americans head to the polls, we’re taking a look at federal lobbying on psychedelics-related matters.
Here, we collate data on formal lobbying activity among psychedelic drug developers and nonprofits, which have collectively funnelled over $1.5 million into such efforts in the last two years.
Psychedelic Drug Developers
First up, let’s look at the lobbying dollars expended by psychedelic drug developers.
To continue reading, and exploring interactive charts, please log in or join Pα+…
Join Pα+ Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space
✓ Regular articles and deep dives across psychedelic research, policy and business
✓ Interviews with insiders
✓ Regular interactive database and commentary on psychedelic patents
✓ Quick-take analysis of major developments
✓ A Library of primers and explainers
✓ Access to our full back catalogue
